Omeros Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Omeros Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 93% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-289.9×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 93% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-6.8×Operating cash was negative last year, while some debt falls due within a year.
Higher than 56% of Healthcare companies in United States.
Cash Cushion Ratio
−6%Debt, after subtracting cash, equals 6% of its market value (net debt).
Lower than 75% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (8)
Omeros Corporation owes $1.18 for every $1 it owns. Omeros Corporation made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
13.6Investors pay $13.6 for every $1 of Omeros Corporation's yearly profit, lower than 76% of Healthcare companies in United States.
P/B ratio
-23.36Omeros Corporation's book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$1.2 BThe total market value of all of Omeros Corporation's shares at today's price (share price × number of shares), larger than 66% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
NegativeOmeros Corporation's net worth is negative ($51 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.18×Omeros Corporation owes $1.18 for every $1 it owns, so it owes more than it owns, higher than 91% of Healthcare companies in United States.
Dividend yield
NoneOmeros Corporation does not currently pay a dividend.
Profit growth
LossOmeros Corporation made a loss in each of the last two years.
Cash vs debt
Net debtOmeros Corporation had $67 M more debt than cash (net debt) at Dec 2025.
Questions
What is Omeros Corporation's P/E ratio?
Investors pay $13.6 for every $1 of Omeros Corporation's yearly profit, lower than 76% of Healthcare companies in United States.
How much does Omeros Corporation owe compared with what it owns?
Omeros Corporation owes $1.18 for every $1 it owns, so it owes more than it owns, higher than 91% of Healthcare companies in United States.
Does Omeros Corporation pay a dividend?
No. Omeros Corporation does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.